“…SJOV via WNJ has been demonstrated to reduce the incidence of hypoxia and improve patient safety in multiple studies under various clinical airway management under sedation/anesthesia 8 , 9 . Unlike transtracheal jet ventilation (TTJV), no barotraumas or sever complications during or after the use of SJOV with WNJ have been reported up to now, although some minor adverse events such as pharyngalgia/xerostomia seems and slight epistaxis 8 , 14 , 15 , 18 , 19 (add references that TTJV cause barotrauma) Notably, pharyngalgia/xerostomia seems to be the most common side effects, with an incidence of about 10–20% 8 , 14 , 15 . However, the risk factors for these side effects with SJOV have not been thoroughly evaluated.…”